Day One Biopharmaceuticals Inc (DAWN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -16,984 | N/A | N/A |
| Accounts payable and accrued liabilities | 14 | N/A | N/A |
| Other Working Capital | 444 | N/A | N/A |
| Other Operating Activity | 12,011 | 0 | 0 |
| Operating Cash Flow | $-4,515 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| Investing Cash Flow | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Debt Issued | 1,000 | N/A | N/A |
| Other Financing Activity | 29,905 | 0 | 0 |
| Financing Cash Flow | $30,905 | $N/A | $N/A |
| Beginning Cash Position | 942 | N/A | N/A |
| End Cash Position | 27,332 | N/A | N/A |
| Net Cash Flow | $26,390 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -4,515 | N/A | N/A |
| Free Cash Flow | -4,515 | 0 | 0 |